Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page footer reflects an updated site revision identifier.SummaryDifference0.0%

- Check12 days agoChange DetectedThe ClinicalTrials.gov record for the completed somapacitan trial is available again, with detailed study information and links to results and supporting documents replacing the access-denied error.SummaryDifference100%

- Check19 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedA site-wide NIH notice announces a website transition and explains that “Super Intelligence” may appear in place of “Artificial Intelligence.” The site revision number also changed.SummaryDifference1%

- Check47 days agoChange DetectedThe site's footer revision number was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record content. Previously visible sponsor and study details are no longer accessible.SummaryDifference22%

Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.